Matching codes
Official code-level notes4
- Includes
- long term (current) drug use for prophylactic purposes
- Excludes 2
- drug abuse and dependence (F11-F19)
- Excludes 2
- drug use complicating pregnancy, childbirth, and the puerperium (O99.32-)
- Code also
- any therapeutic drug level monitoring (Z51.81)
Official code-level notes1
- Excludes 2
- long term (current) use of aspirin (Z79.82)
Official code-level notes1
- Excludes 2
- long term (current) use of aspirin (Z79.82)
Official code-level notes1
- Inclusion terms
- Long term (current) use of birth control pill or patch
Official code-level notes3
- Excludes 2
- long-term (current) use of injectable non-insulin antidiabetic drugs (Z79.85)
- Excludes 2
- long term (current) use of oral antidiabetic drugs (Z79.84)
- Excludes 2
- long term (current) use of oral hypoglycemic drugs (Z79.84)
Official code-level notes2
- Excludes 2
- long term (current) use of steroids (Z79.5-)
- Excludes 2
- long term (current) use of agents affecting estrogen receptors and estrogen levels (Z79.81-)
Official code-level notes4
- Inclusion terms
- Long term (current) use of apremilast
- Inclusion terms
- Long term (current) use of immunomodulatory imide drug
- Inclusion terms
- Long term (current) use of lenalidomide
- Inclusion terms
- Long term (current) use of pomalidomide
Official code-level notes4
- Inclusion terms
- Long term (current) use of adalimumab
- Inclusion terms
- Long term (current) use of etanercept
- Inclusion terms
- Long term (current) use of infliximab
- Inclusion terms
- Long term (current) use of monoclonal antibodies
Official code-level notes2
- Inclusion terms
- Long term (current) use of cyclosporine
- Inclusion terms
- Long term (current) use of tacrolimus
Official code-level notes1
- Inclusion terms
- Long term (current) use of tofacitinib
Official code-level notes1
- Inclusion terms
- Long term (current) use of sirolimus
Official code-level notes3
- Inclusion terms
- Long term (current) use of azathioprine
- Inclusion terms
- Long term (current) use of mycophenolate
- Inclusion terms
- Long term (current) use of purine synthesis (IMDH) inhibitors
Official code-level notes3
- Inclusion terms
- Long term (current) use of chlorambucil
- Inclusion terms
- Long term (current) use of cisplatin
- Inclusion terms
- Long term (current) use of cyclophosphamide
Official code-level notes4
- Inclusion terms
- Long term (current) use of 5-fluorouracil
- Inclusion terms
- Long term (current) use of 6-mercaptopurine
- Inclusion terms
- Long term (current) use of cytarabine
- Inclusion terms
- Long term (current) use of methotrexate
Official code-level notes3
- Inclusion terms
- Long term (current) use of bleomycin
- Inclusion terms
- Long term (current) use of doxorubicin
- Inclusion terms
- Long term (current) use of mitomycin C
Official code-level notes4
- Inclusion terms
- Long term (current) use of paclitaxel
- Inclusion terms
- Long term (current) use of plant alkaloids
- Inclusion terms
- Long term (current) use of vinblastine
- Inclusion terms
- Long term (current) use of vincristine